Chemical Name: P,P'-[1-Hydroxy-2-(3-pyridonyl)ethylidene]bis-phosphonic acid sodium salt
Biological ActivityRisedronate is an orally active biphosphonate that inhibits farnesyl diphosphate (FPP) synthase (IC50 = 100 nM). Exhibits antiproliferative and proapoptotic activity in numerous tumor cell lines and inhibits osteoclast-mediated bone resorption in vivo.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Recent advances in understanding the mechanism of action of bisphosphonates.
Coxon et al.
Lowering bone mineral affinity of bisphosphonates as a therapeutic stragey to optimize skeletal tumor growth inhibition in vivo.
Fournier et al.
Cancer Res., 2008;68:8945
Bisphosphonates in cancer therapy.
Stresing et al.
Cancer Letts., 2007;257:16
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Risedronate
There are currently no reviews for this product. Be the first to review Risedronate and earn rewards!
Have you used Risedronate?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image